Dose Therapeutics: Funding, Investors & Team (Oct 2026)
Dose Therapeutics is a biotechnology company that discovers and develops cutting-edge medicines for treating unmet medical needs. Dose Therapeutics was named in honor of Dr. Donald Seldin, the father of the University of Texas Southwestern Medical Center. It was founded by Deepak Nijhawan and is based in Dallas, Texas.
Dose Therapeutics has raised $10.0M across 1 funding round on record, the most recent an undisclosed round of $10.0M announced in May 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Dose Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2022.
Dose Therapeutics Funding Rounds
Dose Therapeutics Founders and Leadership Team
Contact details for the Dose Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Dose Therapeutics Funding Compared to Other Biotechnology Startups
Dose Therapeutics' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Dose Therapeutics in Biotechnology and Dallas
Companies Similar to Dose Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Dose Therapeutics Funding FAQs
What does Dose Therapeutics do?
Dose Therapeutics is a biotechnology company that discovers and develops cutting-edge medicines for treating unmet medical needs. Dose Therapeutics was named in honor of Dr. Donald Seldin, the father of the University of Texas Southwestern Medical Center. It was founded by Deepak Nijhawan and is based in Dallas, Texas.
How much funding has Dose Therapeutics raised?
Dose Therapeutics has raised $10.0M across 1 round on record. The most recent is an undisclosed round of $10.0M announced in May 2022.
When did Dose Therapeutics last raise funding?
Dose Therapeutics' most recent funding round on record is an undisclosed round of $10.0M, announced in May 2022.
Who founded Dose Therapeutics?
FundedIQ lists Deepak Nijhawan (Founder) at Dose Therapeutics.
Where is Dose Therapeutics headquartered?
Dose Therapeutics is based in Dallas, Texas, United States.
How many employees does Dose Therapeutics have?
Dose Therapeutics is in the 1-10 employee band.
How does Dose Therapeutics' funding compare to other Biotechnology startups?
Dose Therapeutics' latest round of $10.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Dose Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dose Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.